(Press-News.org) The International Vaccine Institute, an international organization with a mission to discover, develop, and deliver safe, effective, and affordable vaccines for global health, began clinical development of DuoChol, a new low-cost oral cholera vaccine (OCV) in capsule form. With funding support from the Wellcome Trust and the Swedish government, IVI is preparing to conduct a Phase I clinical trial of the vaccine in Sweden.
Scientists at the University of Gothenburg developed DuoChol, a dry formulation inactivated bacterial whole cell/cholera toxin B subunit OCV with a similar composition as the world’s first WHO-prequalified OCV, DUKORAL®. While DUKORAL® as well as the currently available WHO-prequalified low-cost OCVs, Shanchol™ and Euvichol-Plus®, both developed at IVI, are drinkable vaccines, what sets DuoChol apart is its dry formulation in capsule form. This presentation improves the vaccine’s thermostability, meaning the active ingredients remain stable at higher relative temperatures for a longer duration, while also reducing its weight and volume.
Dr. Julia Lynch, Director of IVI’s Cholera Program, said: “Oral cholera vaccine is a critical tool in the WHO’s global program for cholera control and elimination. However, with a need that exceeds the current supply of vaccine, the market requires additional producers as well as innovations to make vaccines that are lower cost, easier to use, and more efficacious. DuoChol, with its thermostability and light-weight capsule presentation, has the potential to simplify vaccine storage and delivery, key factors for more effective and efficient vaccination campaigns in outbreak and endemic settings.”
Prof. Jan Holmgren, co-inventor of DuoChol at the University of Gothenburg, said: “We look forward to collaborating with IVI, Valneva and Wellcome Trust in the further development and clinical testing of this novel, improved, thermostable 3rd generation OCV.”
IVI is conducting this study in partnership with Gotovax AB, a biopharmaceutical company spun off from the University of Gothenburg, and Valneva Sweden AB, the Swedish subsidiary of specialty vaccine company Valneva, that was selected to be the contract manufacturing organization (CMO). Valneva will produce DuoChol under good manufacturing practices (GMP) for pre-clinical toxicity testing and the Phase 1 trial.
Dr. Janet Hoogstraate, Managing Director of Valneva Sweden AB, said: “We are excited to work with IVI and Gotovax and look forward to leveraging the competence and experience of our team at Valneva Sweden to deliver clinical trial material for this project.”
Dr Charlie Weller, Head of Infectious Disease Prevention at Wellcome, said: “As we continue to experience a large surge in global cholera cases, the demand for vaccine far outweighs supply. Supporting IVI to take a new, low-cost oral cholera vaccine into a Phase I trial is an important step towards potentially expanding our global toolkit for this escalating disease and making these lifesaving products more accessible to those who need them most. This will be vital for helping to prevent and respond to future cholera outbreaks and save more lives.”
H.E. Anders Nordström, Swedish Ambassador for Global Health, said: “The world is presently faced with a difficult cholera situation, especially in already challenging situations of emergencies and crisis. The development of a new formulation for a low-cost oral cholera vaccine is very important news.”
END
IVI begins clinical development of DuoChol oral cholera vaccine
2023-04-28
ELSE PRESS RELEASES FROM THIS DATE:
Astronomers detect the closest example yet of a black hole devouring a star
2023-04-28
Once every 10,000 years or so, the center of a galaxy lights up as its supermassive black hole rips apart a passing star. This “tidal disruption event” happens in a literal flash, as the central black hole pulls in stellar material and blasts out huge amounts of radiation in the process.
Astronomers know of around 100 tidal disruption events (TDE) in distant galaxies, based on the burst of light that arrives at telescopes on Earth and in space. Most of this light comes from X-rays and optical radiation.
MIT astronomers, tuning past the conventional X-ray and UV/optical bands, have discovered a new ...
Old dogs with dementia sleep less deeply, just like people with Alzheimer’s
2023-04-28
In people with Alzheimer’s, the earliest symptoms are commonly disruptions in sleep rhythms. These include daytime sleepiness, showing agitation or confusion around dusk, staying awake longer, and waking up often at night. These changes are thought to result from damage to sleep-regulating areas in the brain. Alzheimer patients tend to spend less time in both REM (rapid eye movement) sleep, in which most dreaming occurs, and non-REM (NREM) sleep. But they show the greatest reduction in so-called slow-wave sleep (SWS) – a stage of non-dreaming deep sleep, characterized by slow ‘delta’ brain waves (0.1 to ...
Review article on asymmetric synthesis using arynes
2023-04-28
Arynes, synthetic intermediates in which a portion of the benzene ring is a triple bond, have been applied in various organic molecular transformations and have long been of interest to chemists as extremely useful compounds. Furthermore, with the advancement in aryne chemistry, the development of “asymmetric synthesis” reactions of arynes, which are expected to increase the efficiency of the synthesis of compounds with complex steric structures and facilitate the creation of new compounds, has attracted increasing attention.
However, asymmetric synthesis based on arynes, which are extremely reactive and unstable, presents several challenges. Therefore, asymmetric ...
Study: Hypothermia more likely in Black, Asian newborns
2023-04-28
Newborns of Black and Asian mothers are significantly more likely to experience hypothermia than those born to white mothers, according to a new study. The research will be presented at the Pediatric Academic Societies (PAS) 2023 Meeting, held April 27-May 1 in Washington, D.C.
Researchers reviewed electronic medical records of 23,549 infants born at 35 weeks or later and admitted to a children’s hospital-affiliated newborn nursery between 2015 and 2021. The study evaluated all recorded temperatures ...
Study: Highly educated Black women experience poorer maternal outcomes
2023-04-28
Black mothers with a master’s or doctorate degree experienced some of the worst birth outcomes, compared to Black mothers with less education and white mothers with the same or less education, according to a new study. The research will be presented at the Pediatric Academic Societies (PAS) 2023 Meeting, held April 27-May 1 in Washington, D.C.
Researchers examined how educational achievement and race affected preterm births and low birth weights for babies born to non-Hispanic Black and white women ...
Study: Common treatment for brain injury not effective for some newborns
2023-04-28
Therapeutic hypothermia, the only evidence-based treatment for newborns born with neonatal encephalopathy (NE) at or after 36 weeks, is not effective for reducing death or moderate/severe disability in newborns born between 33 and 35 weeks, according to a new study. The research will be presented at the Pediatric Academic Societies (PAS) 2023 Meeting, held April 27-May 1 in Washington, D.C.
Researchers examined the effectiveness of whole-body therapeutic hypothermia—a commonly used treatment to lower newborns’ body temperature and protect against the effects of moderate or severe NE—in younger newborns. NE is a brain condition experienced at or near birth, ...
Study: Lenient gun laws pose threat to public safety
2023-04-28
Children in states with minimal firearm policies have a significantly higher death rate compared to those in states with strict gun laws, according to a new national study. The research will be presented at the Pediatric Academic Societies (PAS) 2023 Meeting, held April 27-May 1 in Washington, D.C.
The study analyzed 6,491 pediatric firearm-related deaths between 2016 and 2020 from the Centers for Disease Control and Prevention, along with state rankings for firearm legislation from Giffords Law Center, a national nonprofit that tracks and analyzes firearm legislation in all 50 states. States are ranked on the strength of gun laws on a scale from least lenient to most ...
Study: Black youth most likely to receive drug restraints for mental health
2023-04-28
Non-Hispanic Black youth between the ages of 5 and 18 years old are more likely to undergo pharmacologic restraint during mental health crises than children of other races and ethnicities. The findings will be presented at the Pediatric Academic Societies (PAS) 2023 Meeting, held April 27-May 1 in Washington, D.C.
The study examined records of 61,503 children admitted to 41 non-psychiatric U.S. children’s hospitals between 2018 and 2022 due to mental health conditions such as autism, anxiety, psychotic disorders, self-injury or suicide, and trauma. Approximately 11.9% received pharmacologic restraint, a deliberate form of medication ...
Study: Adherence to pediatric vaccine recommendations on the rise
2023-04-28
The percentage of children under 19 months who received all recommended vaccines on-time steadily improved from 22.5% in 2011 to 34.9% in 2020, according to a new national study. The research will be presented at the Pediatric Academic Societies (PAS) 2023 Meeting, held April 27-May 1 in Washington, D.C.
Researchers examined 161,187 child vaccination records over a 10-year period for the combined seven-vaccine series of diphtheria, pertussis, tetanus, poliovirus, measles, mumps, rubella, hepatitis B, Haemophilus influenzae type b, varicella, and pneumococcal infections. The records came from ...
Study: Clinician reminders in EHRs improve asthma care
2023-04-28
Asthma care reminders for clinicians improve patients’ use of preventive medication and reduce caregiver’s concerns about these medications, according to a new study. The findings will be presented at the Pediatric Academic Societies (PAS) 2023 Meeting, held April 27-May 1 in Washington, D.C.
Researchers conducted a trial of 530 children with persistent or uncontrolled asthma at 18 pediatric and family medicine clinics in the Bronx, New York, to determine how the inclusion of clinician reminders about asthma severity and care guidelines in electronic ...